# US 2018/0021335 A1 · Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2018/0021335 A1
- Document ID: US20180021335A1
- Status: Published application
- Kind: A1
- Application number: 15/659,808
- Filed: 2017-07-26
- Published: 2018-01-25
- Earliest claimed: 2006-12-28
- Assignees: CymaBay Therapeutics, Inc.
- Applicants: CymaBay Therapeutics, Inc.
- Inventors: Xin Chen; Peng Cheng; L. Edward Clemens; Jeffrey D. Johnson; Jingyuan Ma; Alison Murphy; Imad Nashashibi; Christopher J. Rabbat; Jiangao Song; Maria E. Wilson; Yan Zhu; Zuchun Zhao
- Web page: https://patentgrep.com/patent/US20180021335A1

## CPC

- A61K 31/506: not condensed and containing further heterocyclic rings
- A61K 31/454: containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
- A61P 3/00: Drugs for disorders of the metabolism (of the blood or the extracellular fluid A61P7/00)
- A61P 3/04: Anorexiants; Antiobesity agents
- A61P 3/06: Antihyperlipidemics
- A61P 3/08: for glucose homeostasis (pancreatic hormones A61P5/48)
- A61P 3/10: for hyperglycaemia, e.g. antidiabetics
- A61P 9/00: Drugs for disorders of the cardiovascular system
- A61P 9/10: for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A61P 9/12: Antihypertensives
- A61P 13/12: of the kidneys
- A61P 27/02: Ophthalmic agents
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 277/42: Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
- C07D 401/04: directly linked by a ring-member-to-ring-member bond
- C07D 401/14: containing three or more hetero rings
- C07D 413/04: directly linked by a ring-member-to-ring-member bond
- C07D 413/14: containing three or more hetero rings
- C07D 417/04: directly linked by a ring-member-to-ring-member bond
- C07D 417/14: containing three or more hetero rings
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)

## Abstract

Compounds and methods are provided for the treatment of, inter alia, Type II diabetes and other diseases associated with poor glycemic control. The compounds of the invention are orally active.

## Claims

### Claim at position 1

1-61. (canceled)

### Claim 62

A method of increasing a level of cyclic AMP, insulin, or incretin in a patient in need thereof, comprising administering to the patient a DPP-IV inhibitor and a compound selected from the group consisting of
or a pharmaceutically acceptable salt thereof.

### Claim 63 (depends on 62)

The method of claim 62 wherein said compound of Formula (I) is
or a pharmaceutically acceptable salt thereof.
